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Abstract
Physical activity is emerging as an alternative nonpharmaceutical strategy to prevent
and treat a variety of cardiovascular diseases due to its cardiac and skeletal muscle
beneficial effects. Oxidative stress occurs in skeletal muscle of chronic heart failure
(CHF) patients with possible impact on muscle function decline. We determined
the effect of voluntary-free wheel running (VFWR) in preventing protein damage in
Tgaq*44 transgenic mice (Tg) characterized by a delayed CHF progression. In the
early (6 months) and transition (12 months) phase of CHF, VFWR increased the
daily mean distance covered by Tg mice eliminating the difference between Tg and
WT present before exercise at 12 months of age (WT Pre-EX 3.62  1.66 vs. Tg
Pre-EX 1.51  1.09 km, P < 0.005; WT Post-EX 5.72  3.42 vs. Tg Post-EX
4.17  1.8 km, P > 0.005). This effect was concomitant with an improvement of
in vivo cardiac performance [(Cardiac Index (mL/min/cm2): 6 months, untrained-
Tg 0.167  0.005 vs. trained-Tg 0.21  0.003, P < 0.005; 12 months, untrained-Tg
0.1  0.009 vs. trained-Tg 0.133  0.005, P < 0.005]. Such effects were associated
with a skeletal muscle antioxidant response effective in preventing oxidative damage
induced by CHF at the transition phase (untrained-Tg 0.438  0.25 vs. trained-Tg
0.114  0.010, P < 0.05) and with an increased expression of protein control mark-
ers (MuRF-1, untrained-Tg 1.12  0.29 vs. trained-Tg 14.14  3.04, P < 0.0001;
Atrogin-1, untrained-Tg 0.9  0.38 vs. trained-Tg 7.79  2.03, P < 0.01; Cathepsin
L, untrained-Tg 0.91  0.27 vs. trained-Tg 2.14  0.55, P < 0.01). At the end-stage
of CHF (14 months), trained-Tg mice showed a worsening of physical performance
(decrease in daily activity and weekly distance and time of activity) compared to
trained age-matched WT in association with oxidative protein damage of a similar
level to that of untrained-Tg mice (untrained-Tg 0.62  0.24 vs. trained-Tg
0.64  0.13, P > 0.05). Prolonged voluntary physical activity performed before the
onset of CHF end-stage, appears to be a useful tool to increase cardiac function and
to reduce skeletal muscle oxidative damage counteracting physical activity decline.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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INTRODUCTION
It is now widely accepted that chronic physical activity is
beneficial for cardiac health emerging as an alternative
nonpharmaceutical strategy to prevent and treat a variety
of cardiovascular diseases, since it promotes a broad
range of cardiac and skeletal muscle beneficial effects
(Ventura-Clapier et al., 2007; Hirai et al., 2015).
Beyond overt cardiovascular alterations, patients with
chronic heart failure (CHF) also show exercise intolerance
(Poole et al., 2012; Hirai et al., 2015), that affects the
patients’ clinical picture, quality of life, and prognosis.
Several evidences indicate that changes in cardiac function
cannot fully explain the origin of exercise intolerance
(Piepoli et al., 2010) and a key role of the periphery has
emerged, indicating that changes in skeletal muscle can
significantly limit exercise capacity in these patients. The
impairment also precludes these patients from obtaining
the beneficial effects associated with exercise training
(Hirai et al., 2015). Therefore, to improve the quality of
life of these patients the development of countermeasures
that positively affect both cardiac and skeletal muscle is
essential.
Different training modalities are available to target the
problems with which chronic heart failure patients are
faced and low stress exercise is now recommended for
these patients (Aronow, 2003; Pi~na et al., 2003; Smart
and Marwick, 2004).
Voluntary wheel running in rodents is used as a para-
digm to assess physical performance and endurance and
also to simulate endurance training in humans. The
nonforced voluntary wheel running represents a less
stressful and more respectful of circadian rhythm inter-
vention than forced running, (Sexton, 1995) able to pro-
vide sufficient stimuli for cardiac adaptation (Allen
et al., 2001; Natali et al., 2001). Recently, several evi-
dences indicate that voluntary physical activity (free
wheel running) has a positive impact on cardiac func-
tion in animal models of CHF (Deloux et al., 2017;
Grassi et al., 2017; Tyrankiewicz et al., 2017) but it fails
to normalize the derangement of skeletal muscle oxida-
tive metabolism associated with the disease (Schultz
et al., 2013; Grassi et al., 2017) leaving doubts about the
efficacy of free wheel running on skeletal muscle of car-
diopathic subjects.
Considering that in healthy conditions, long-term volun-
tary wheel running increases oxidative enzymes levels and
PGC-1a specifically in fast skeletal muscles (Ikeda et al.,
2006), this could be the reason for its ineffectiveness in
affecting skeletal muscle oxidative metabolism in soleus
muscle of mice with CHF (Grassi et al., 2017).
Moreover, in addition to metabolic alterations, CHF
induces several other alterations in skeletal muscle that
include change in content and activity of key radical scav-
enger enzymes, leading to an increased oxidative stress
(Linke et al., 2005; Coirault et al., 2007; Bowen et al.,
2015). It is well-known that under oxidative stress condi-
tions, as in muscles with CHF, the excessive production
of reactive oxygen species (ROS) promotes oxidative
damage at the proteins level, that is, protein carbonyla-
tion, altering tissue homeostasis. In this context, a dele-
terious effect on in vitro mechanical function due to
the myosin carbonylation in skeletal muscle of rats with
CHF has been reported (Coirault et al., 2007). Within
cells, proteins are under constant surveillance by the
proteolytic systems that promote the degradation of
proteins damaged by highly reactive molecules, thus
operating a protein quality control and preserving mus-
cle health (Kaushik and Cuervo, 2015). Interestingly,
reduced oxidative stress (Skop et al., 2015) and increase
in proteasome-mediated proteolysis has been found fol-
lowing both acute (Pasiakos et al., 2010) and chronic
endurance exercise (Cunha et al., 2012b) in healthy
conditions.
Whether voluntary wheel running is effective in pre-
venting or normalizing oxidative stress and at what stage
of the CHF it shows its effectiveness is still unknown. In
this study we aimed to determine the impact of voluntary
exercise (1) on molecular parameters involved in oxida-
tive metabolism and (2) on normalization of the redox
status in the fast gastrocnemius muscle, at different times
during the progression of the disease. We hypothesize
that voluntary exercise, thanks to its ability to induce
catabolic systems activation, promotes an antioxidant
effect on skeletal muscle favoring the elimination of oxi-
dized damaged proteins and thus improving physical
activity level of cardiopathic mice.
In order to do so, we utilized the Tgaq*44 mice, a
transgenic mouse model characterized by a delayed pro-
gression from cardiac hypertrophy to overt CHF similar
to that described (although over a substantially longer
time period) in human patients (Braunwald, 2013), and
voluntary-free wheel running.
MATERIALS AND METHODS
Ethical approval
All animal experiments were conducted according to the
National Institutes of Health Guide for the Care and Use
of Laboratory Animals and were approved by the local
animal protection committee (Local Bioethics Committee
in Krakow, approvals No. 914/2012 and 27/2014). The
investigators understand the ethical principles under
which this journal operates and confirm that the work
complies with the journal animal ethics checklist.
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Study design and animal care
The experiments were carried out at three time points,
corresponding to different stages of the developing CHF:
4 months of age, at which mice exhibited no functional
impairments (early phase of CHF), 10 months of age, that
is, in mice with impairments of cardiac contractile and
mitochondrial functions (transition phase of CHF) and
12 months of age, at which mice exhibited signs of end-
stage heart failure (end-stage of CHF). Adult female FVB
wild-type (WT) and homozygous Tgaq*44 transgenic (Tg)
mice from several litters were mixed and divided into three
age groups (4 months old; 10 months old; 12 months old
at the start of the study) and randomized to either seden-
tary (WT-CTRL n = 11, Tg-CTRL n = 11) or trained
group (WT-T n = 11, Tg-T n = 11) for each age group.
The analyses were performed in a blinded manner. The
training groups were placed in cages equipped with a run-
ning wheel, allowing to record the animals’ voluntary wheel
running activity during a period of 8 weeks. The animals uti-
lized in this study were bred at the Institute of Experimental
and Clinical Medicine of the Polish Academy of Sciences in
Warsaw (Poland). Prior to the experiments the animals were
transported to the animal house at the Faculty of Pharmacy,
Medical College, Jagiellonian University in Krakow (Poland).
Mice were housed one per cage (floor area of
355 9 235 9 190 mm) and maintained at 22–24°C under a
12-h light cycle with ad libitum access to water and rodent
chow. The training groups were placed in cages equipped
with a running wheel allowing to perform voluntary running
activity (see below). For skeletal muscle analysis, the animals
of WT-CTRL, Tg-CTRL, and Tg-T groups were killed at
24 h after the last running activity (T groups) by cervical dis-
location after euthanasia with ketamine and xylazine (100
and 10 mg/kg intraperitoneal injection, respectively). Gas-
trocnemius was dissected, immediately frozen in liquid
nitrogen and stored at 80°C. Molecular analysis was per-
formed on 4–5 muscle samples for each group.
Running wheel activity
After a familiarization period with the wheel, voluntary
wheel running activity of each mice was recorded contin-
uously using the Running Wheel System (Columbus
Instruments Inc., Ohio). The system was programmed to
record all running episodes that lasted more than 10 sec.
Moreover, the mice were monitored by a digital camera
placed in the animal house, allowing the supervising per-
son to check the mice behavior at a given time without
disturbing its normal life. Based on the number of revolu-
tions of the wheel and its radius, the covered distance
and the running velocity of the animals were calculated.
The data were stored in a computer and were
downloaded on a weekly basis. The individual data of
covered distance and velocity of running were expressed
as a mean  SD value per 24 h, and were further aver-
aged for the entire period of training (56 days).
Magnetic resonance in vivo study
In vivo cardiac performance was assessed using a 9.4T MRI
system (BioSpec, Bruker BioSpin, Ettlingen, Germany) with
protocols as described previously (Wojewoda et al., 2016).
Briefly, 2D IntragateTM FLASH sequence was used
(TE = 1.49 ms; TR = 4.3 ms; flip angle, 18°; number of
repetitions, 250; field of view, 30 9 30 mm2; matrix size,
256 9 256; slice thickness, 1.0 mm). Image reconstruction
was made using the IntraGate 1.2.b.2 macro (Bruker) into
a 60-frame-per-cardiac-cycle movie (or 30 in case of left
atrium analysis). Short-axis views covering the entire left
ventricle (LV) were used for LV assessment. Segment pack-
age (Heiberg et al., 2010) (v.1.9 R2626, Medviso AB, Lund,
Sweden) was used for the LV delineation. The end-dias-
tolic/end-systolic volumes (EDV/ESV), ejection fraction
[EF = (EDV – ESV)/EDV], cardiac output (CO = SV 9
HR, where HR is heart rate) were assessed directly using
resulting time-volume (TVC) curve. Left atrial (LA) func-
tion was assessed from three long-axis views at the end of
systole and diastole (Tyrankiewicz et al., 2016). Mice were
examined under gas anesthesia: 1.7% of isoflurane (Aer-
rane, Baxter, Deerfield, IL) with oxygen and air in relation
1:2 and under stabilized temperature, maintained at 37°C.
During MRI protocols following parameters were moni-
tored: electrocardiogram (R-R peak intervals), respiration
(frequency), and body temperature (maintained at 37°C by
water jacket heating). For physiological parameter the
tracking Monitoring and Gating System (Model 1025, SA
Inc., Stony Brook, NY) was used. Due to the fact that some
animals did not present satisfactory ECG signal, which is
needed for proper MRI triggering, the number of animals
indicated in Table 1 is lower.
Analysis of MHC isoform content
The myosin heavy chain (MHC) isoform composition was
determined using an electrophoretic approach previously
described in detail (Brocca et al., 2010). Frozen muscles
were pulverized in a steel mortar with liquid nitrogen to
obtain a powder that was immediately re-suspended in
Laemmli solution (62.5 mmol/L Tris-HCl pH 6.8, 2.3%
SDS, 10% glycerol, 5% b-mercaptoethanol, and 0.01% bro-
mophenol blue). Protein concentration was determined
with a protein assay kit (RC DC; Bio-Rad, Hercules, CA).
The lysates were loaded onto 8% SDS-PAGE polyacry-
lamide gels and electrophoresis was run for 2 h at 200 V
and then for 24 h at 250 V. Following Coomassie staining,
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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four bands corresponding to MHC isoforms were obtained
and a densitometric analysis was performed to assess the
relative proportion of MHC isoforms in the samples.
Gene expression analysis
Total RNA was extracted from muscles using an SV Total
RNA isolation kit (Promega, Madison, WI). The RNA con-
centration was measured using a NanoDrop instrument
(Thermo Scientific, Waltham, MA) and 300 ng was used to
generate cDNA with Super-Script III reverse transcriptase
(Invitrogen, Carlsbad, CA). The cDNA was analyzed by
quantitative real-time PCR (AB 7500) using a SYBR Green
PCR kit (Applied Biosystems, Foster City, CA) and the data
were normalized to PPIA (peptidylprolyl isomerase A)
expression (Cannavino et al., 2015b). The oligonucleotide
primers used were as follows: Atrogin-1 Forward GCAAA-
CACTGCCACATTCTCTC Reverse CTTGAGGGGAAAG
TGAGACG; MuRF-1 Forward ACCTGGTGGAAAACA
TC Reverse CTTCGTGTTCCTTGCACATC; Cathepsin L
Forward GCGCGTGACTGGTTGAG Reverse AAAGGCA
GCAAGGATGAGTG.
Western blot analysis
As previously described (Cannavino et al., 2015a), frozen
muscle samples were pulverized in a steel mortar with
liquid nitrogen and suspended in a lysis buffer (20 mmol/
L Tris-HCl, 1% Triton X-100, 10% glycerol, 150 mmol/L
NaCl, 5 mmol/L EDTA, 100 mmol/L NaF, and 2 mmol/L
NaPPi supplemented with 1 9 protease, phosphatase
inhibitors [(Sigma-Aldrich, St Louis, MO) and 1 mmol/L
phenylmethane sulphonyl fluoride (PMSF)]. The lysate
was left for 20 min in ice then centrifuged at 18,000g for
20 min at 4°C. Protein concentration was determined on
the supernatant using the RC DCTM protein assay kit
(Bio-Rad). Samples were stored at –80°C until ready to
use. 40 µg of proteins was loaded onto 12% gradient pre-
cast gels (Any kD Mini-PROTEAN TGX; Bio-Rad). Pro-
teins were electrotransferred to polyvinylidene difluoride
membranes at 100 V for 2 h at 4°C in a transfer buffer
containing 25 mmol/L Tris, glycine 192 mmol/L, and
20% methanol. The membranes were probed with specific
primary antibodies and subsequently with HRP-conju-
gated secondary antibody. Protein bands were visualized
by an enhanced chemiluminescence method using a digi-
tal imaging system (ImageQuant LAS 4000; GE Health-
care, Litle Chalfont, UK). Protein bands were normalized
on actin stained with Ponceau Red. To allow the compar-
ison of samples from different membranes a calibrator
sample was loaded in each membrane. The activity levels
of AMPKa (5’ adenosine monophosphate-activated pro-
tein kinase) were calculated as the ratio between the con-
tent in the phosphorylated (p) and total forms.
Table 1. Cardiac performance in Tgaq*44 mice before and after 2 months of spontaneous activity
Tg-6mo Tg-12mo Tg-14mo
Tg-CTRL (n = 7) Tg-T (n = 11) Tg-CTRL (n = 7) Tg-T (n = 10) Tg-CTRL (n = 7) Tg-T (n = 13)
Body mass 25.8  0.5 24.9  0.5 29.5  3.0+ 28.6  1.3 29.2  0.7+ 28.5  0.4
CI [mL/min/cm2] 0.167  0.005 0.21  0.003* 0.101  0.009 0.133  0.005* 0.116  0.005 0.119  0.005
HR [bpm] 491  9 499  3 348  14+ 361  9 321  7+ 321  6
ESV [lL] 20.0  0.9 25.0  1.3* 31.9  3.2 29.9  1.3 32.5  3.5+ 30.1  3.8
EDV [lL] 49.2  1.1 60.3  1.6* 59.3  3.4 63.7  2.0 65.1  4.7+ 62.6  4.4
SV [lL] 29.2  0.7 35.2  0.7* 27.4  2.4 33.7  1.1* 32.6  2.0 32.5  1.1
EF [%] 59.5  1.4 58.7  1.4 46.5  4.4+ 53.0  1.1* 51.5  2.9 53.6  3.2
ER [SV/RR] 2.91  0.13 3.15  0.10* 3.65  0.38 4.03  0.24* 4.02  0.18+ 3.99  0.10
FR [SV/RR] 4.01  0.15 3.75  0.10 5.11  0.42 5.71  0.62 5.61  0.46+ 5.29  0.32
ET [%RR] 39.5  1.4 32.3  1.0* 30.0  2.2 27.0  1.8* 27.4  1.4+ 25.9  0.9
IVRT [%RR] 13.0  0.7 14.7  0.8* 9.2  2.3 11.9  0.9 11.2  0.9 10.5  0.6
FT [%] 34.5  1.8 37.7  1.2 28.1  4.0 27.5  1.9 25.2  2.4+ 25.8  2.9
IVCT [% RR] 12.9  0.6 15.2  0.7 32.7  5.0+ 33.5  2.4 36.1  2.9+ 37.6  2.7
LA EF [%] 0.16  0.03 0.23  0.01* 0.10  0.04 0.14  0.02 0.05  0.01+ 0.06  0.01
CI, Cardiac Index; CHF, chronic heart failure; HR, Heart Rate; ESV, End Systolic Volume; EDV, End Diastolic Volume; SV, Stroke Volume; EF,
Ejection Fraction; ER, Ejection Rate; FR, Filling Rate (ER and FR were normalized to individual SV and R-R values); ET, Ejection Time; IVRT, Isovo-
lumic Relaxation Time; FT, Filling Time; IVCT, Isovolumic Contraction Time; LAEF, Left Atrial Ejection Fraction.
Cardiac parameters of transgenic mice at different stages of CHF;
*Significantly different from untrained Tg mice (Tg-CTRL) at given age (P < 0.05, t-test);
+Significantly different between transgenic mice (Tg-CTRL) at a given age as compared to 6 months old Tg-CTRL mice (P < 0.05; One-way
ANOVA); No differences were detected between Tg-CTRL at the age of 12 and 14 months of age.
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The primary antibodies used were as follows: rabbit p-
AMPK (thr 172) (Cell Signaling); rabbit AMPK (Cell Sig-
naling); rabbit PGC-1a (Abcam); mouse OXPHOS com-
plexes (Abcam); rabbit DRP1 (Cell Signaling); rabbit
SOD1 (Abcam); rabbit Catalase (Abcam); rabbit LC3B
(Sigma-Aldrich); and anti-rabbit IgG (Cell Signaling).
Oxyblot analysis
Muscle samples previously stored at 80°C were pulverized
and homogenized at 4°C in an antioxidant buffer contain-
ing protease inhibitors, 25 mm imidazole and 5 mm
EDTA, pH 7.2 adjusted with NaOH as previously described
in detail (Brocca et al., 2010). The lysate was left for 20 min
in ice and the homogenate obtained was centrifuged at
18,000g for 20 min at 4°C. Protein concentration was
determined on the supernatant using the RC DCTM pro-
tein assay kit (BioRad). The supernatant was stored at
80°C until ready to use. The protein carbonylation level
was detected using the OxyBlot Kit (AbNova, Taipei City,
Taiwan), which provides reagents for sensitive immunode-
tection of these carbonyl groups. The carbonyl groups in
the protein side chains are derivatized to 2,4-dinitrophenyl-
hydrazone (DNP hydrazone) by reaction with 2,4-dinitro-
phenylhydrazine (DNPH); 12 lg of the DNP-derivatized
protein samples were separated by PAGE (12% SDS-poly-
acrylamide gels) and then blotted for 2 h at 100 V to a
nitrocellulose membrane. Membranes obtained were
stained with Ponceau Red and then scanned. Membranes
were incubated with primary antibody, specific to the DNP
moiety of the proteins and subsequently with an HRP–anti-
body conjugate directed against the primary antibody (sec-
ondary antibody: goat anti-rabbit IgG). Blots were
developed using an enhanced chemiluminescence method.
Positive bands emitting light were detected by short expo-
sure to photographic films. Protein oxidation was quanti-
fied by defining the oxidative index (OI), that is, the ratio
between densitometric values of the oxyblot bands and
those stained with Ponceau Red.
Statistical analysis
Data were tested for normal distribution by the Kol-
mogorov–Smirnov test. Data are represented as mean
values  SD. Statistical analysis was evaluated using the
GraphPad Prism software (GraphPad Software) and
assessed by a Student’s t-test between Trained and Con-
trol mice (P < 0.05) at given age. Difference between
transgenic mice (Tg-CTRL) at a given age were assessed
by One-way ANOVA followed by Tuckey’s multicompar-
isons test or Kruskal–Wallis nonparametric test
(P < 0.05). Two-way ANOVA followed by Bonferroni
post hoc test was used for comparisons of molecular
data between groups at different stages of CHF
(P ˂ 0.05).
RESULTS
In vivo functional performance before and
after 2 months of voluntary exercise
Functional performance was evaluated by measuring the
total covered distance (km) and the total time (h) spent
running during 2 months of voluntary-free wheel running
(VFWR).
Tg-T mice showed a decline in physical activity only in
the late phase of the disease. In fact, at 14 months of age
both weekly distance [delta (WT-T-Tg-T)  40.72 km]
and time [delta (WT-T-Tg-T)  19 h] spent on the wheel
(Fig. 1A and B) were significantly lower in Tg-T with
respect to the age-matched WT-T. Both weekly distance
and time of running of Tg-T at 6 and at 12 months of
age were not significantly different from their age-
matched WT-T. The comparison of daily covered distance
before (Pre-EX) and after (Post-EX) 2 months of VFWR,
showed a significant improvement of physical activity
level in Tg mice (Fig. 1C) at all ages. VFWR eliminated
the difference in daily performance between Tg and WT
present before exercise at 12 months of age (WT Pre-EX
3.62  1.66 km vs. Tg Pre-EX 1.51  1.09 km,
P < 0.005; WT Post-EX 5.72  3.42 km vs. Tg Post-EX
4.17  1.8 km, P > 0.005).
Although the positive effect of exercise at all stage of the
disease, at 14 months of age a significant functional gap
between WT and Tg mice was observed, as indicated by
the significant decrease in weekly distance (Fig. 1A) and
time (Fig. 1B) and daily distance (Fig. 1C) of running.
Cardiac performance before and after
2 months of voluntary exercise
Results related to cardiac performance in Tg mice are
presented in Table 1. Parameters related to cardiac func-
tion were found altered in 12 and 14 months Tg-CTRL
old mice compared to those of Tg-CTRL at 6 months of
age. More precisely, a significant decreased of ejection
fraction (EF), heart rate (HR), and prolonged sovolumic
contraction time (IVCT) was found at the age of
12 months. Further deterioration was observed in
14 months-old mice as decreases in left atrial ejection
fraction (LA EF), increases in end systolic volume (ESV),
end diastolic volume (EDV), ejection rate (ER) and filling
rate (FR), reduction of ejection time (ET), filling time
(FT), and heart rate (HR) and further prolongation of
IVCT. No differences were detected between Tg-CTRL at
the age of 12 and 14 months of age.
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Spontaneous activity improved cardiac performance in
mice at the early and at the transition phase of CHF by
increasing Cardiac Index (CI) (at 6 months, Tg-CTRL
0.167  0.005 vs. Tg-T 0.21  0.003 P < 0.05; at
12 months, Tg-CTRL 0.101  0.009 vs. Tg-T
0.133  0.005 P < 0.05), Stroke Volume (SV) (at
6 months, Tg-CTRL 29.2  0.7 vs. Tg-T 35.2  0.7
P < 0.05; at 12 months, Tg-CTRL 27.4  2.4 vs. Tg-T
33.7  1.1 P < 0.05), ER (at 6 months, Tg-CTRL
2.91  0.13 vs. Tg-T 3.15  0.1 P < 0.05; at 12 months,
Tg-CTRL 3.65  0.38 vs. Tg-T 4.03  0.24 P < 0.05), and
by shortening ET (at 6 months, Tg-CTRL 39.5  1.4 vs.
Tg-T 32.3  1 P < 0.05; at 12 months, Tg-CTRL 30  2.2
vs. Tg-T 27  1.8 P < 0.05). At the early phase of CHF
spontaneous activity additionally significantly increased
ESV (Tg-CTRL 20  0.9 vs. Tg-T 25  1.3 P < 0.05),
EDV (Tg-CTRL 49.2  1.1 vs. Tg-T 60.3  1.6 P < 0.05)
and LA EF (Tg-CTRL 0.16  0.03 vs. Tg-T 0.23  0.01
P < 0.05), and prolonged Isovolumic Relaxation Time
(IVRT) (Tg-CTRL 13  0.7 vs. Tg-T 14.7  0.8 P < 0.05).
In vitro skeletal muscle determinations
before and after 2 months of voluntary
exercise
In order to understand the efficacy of voluntary exercise
in normalizing molecular parameters associated with
CHF, the WT-CTRL, Tg-CTRL, and Tg-T groups were
analyzed as follows:
MHC isoforms composition before and after
2 months of voluntary exercise
MHC isoform composition was determined as an index
of fiber-type composition. At 6 months of age CHF
induced a significant slow-to-fast shift in MHC composi-
tion, as indicated by the significantly higher fast MHC-2B
content, with concomitant significantly lower contents of
MHC-1 and MHC-2A, observed in Tg-CTRL in compar-
ison with WT-CTRL (Fig. 2). Exercise training induced a
significant reduction in MHC-2B and a concomitant
increase in MHC-1 and MHC-2A, in comparison with
Tg-CTRL. No significant effects of CHF and exercise
training on MHC isoform content were found at
12 months of age. At 14 months of age Tg-CTRL mice
showed a substantial reduction in MHC-2A and MHC-1,
with a concomitant significant increase in MHC-2X with
respect to WT-CTRL. Exercise training restored the con-
trol phenotype at 6 months of age and partially at
14 months.
Antioxidant enzymes and protein
carbonylation before and after 2 months of
voluntary exercise
Since an increase in ROS production has been demon-
strated in muscles of CHF patients, we studied the devel-
opment of redox imbalance during the progression of the
disease by evaluating the protein level of two antioxidant
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enzymes, superoxide dismutase 1 (SOD1) and catalase,
and the level of protein carbonylation. In Tg-CTRL mice
a significantly lower SOD1 content was found at 6 and
14 months of age, in comparison to the WT-CTRL
group. Exercise training significantly counteracted SOD1
reduction only in the late stage of the disease (14 months
of age) (Fig. 3A). Catalase protein level was found signifi-
cantly reduced at 6 and 12 months of age in Tg-CTRL
mice versus WT-CTRL, and its expression was not signifi-
cantly modified by exercise training at any age (Fig. 3B).
Protein carbonylation was significantly higher in Tg-
CTRL versus WT-CTRL at 12 (0.438  0.25 vs.
0.053  0.1 P < 0.05) and 14 (0.623  0.24 vs.
0.095  0.087 P < 0.01) months of age. Exercise pre-
vented oxidative protein damage only at 12 months of
age (Tg-CTRL 0.438  0.25 vs. Tg-T 0.114  0.01
P < 0.05) (Fig. 3C).
Protein quality control system before and
after 2 months of voluntary exercise
As the ubiquitine–proteasome system and autophagy are
the major systems involved in protein quality control, we
measured the mRNA levels of the muscle-specific ubiqui-
tin E3-ligases, Atrogin-1, and MuRF-1, which belong to
ubiquitine–proteasome system, and LC3 protein level and
Cathepsin-L mRNA levels as markers of the autophagy
machinery. In the intermediate phase of CHF (12 months
of age) Tg-CTRL showed significantly lower mRNA levels
of Atrogin-1 and MuRF-1, with respect to WT-CTRL
(Fig. 4A and B). In Tg-T, Atrogin-1 and MuRF-1 levels
increased with training with respect to Tg-CTRL (at
6 months, MuRF-1, Tg-CTRL 1.65  0.47 vs. Tg-T
6.2  0.99 P < 0.001; Atrogin-1, Tg-CTRL 2.34  1.11
vs. Tg-T 14.02  9.3 P < 0.0001; at 12 months, MuRF-1,
Tg-CTRL 1.12  0.29 vs. Tg-T 14.14  3.04 P < 0.0001;
Atrogin-1, Tg-CTRL 0.9  0.38 vs. Tg-T 7.79  2.03
P < 0.01), with the exception of the late stage of the dis-
ease (14 months) (Fig. 4A and B).
As regards markers of autophagy, LC3II/LC3I was not
affected by CHF at all stages of the disease (Fig. 4C).
Cathepsin-L was found significantly increased in Tg-CTRL
mice at 6 months, and decreased at 12 months (Fig. 4D).
Exercise-induced autophagy through the increase in LC3II/
LC3I at 6 months (Tg-CTRL 0.377  0.069 vs. Tg-T
0.883  0.15 P < 0.01) and Cathepsin-L at 12 months
(Tg-CTRL 0.915  0.27 vs. Tg-T 2.14  0.55 P < 0.01). In
the late stage of the disease (14 months) exercise training
failed to induce autophagy.
AMPK and its targets before and after
2 months of voluntary exercise
AMPK functions as a central mediator of the cellular
response to energetic stress controlling mitochondrial
homeostasis (Herzig and Shaw, 2018). Figure 5A shows
changes in AMPK activation, evaluated by the ratio
between the phosphorylated and total AMPK (p-AMPK/
AMPK). In Tg-CTRL, at all stages of disease, p-AMPK/
AMPK was significantly lower with respect to WT-CTRL.
In Tg-T exercise induced a significant p-AMPK/AMPK
increase; at 12 months of age the increase was not statisti-
cally significant. As shown in panel B, a decrease in PGC-
1a protein content was found in Tg-CTRL mice with
respect to the age-matched WT-CTRL mice, in all phases
of the disease (although at 14 months of age the differ-
ence did not reach statistical significance), suggesting that
the basal level of mitochondrial biogenesis was impaired
by CHF. Exercise training induced a significant PGC-1a
increase in Tg-T mice only at 14 months of age.
Since the key to maintaining mitochondrial health is
mitochondrial dynamics and AMPK is a crucial regulator
of this process, we analyzed the expression of the profission
dynamin fission-related protein 1 (DRP1) and the
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profusion mitofusin1 (Mfn1). Tg-CTRL mice showed a sig-
nificantly lower DRP1 content, with respect to the age-
matched WT-CTRL mice, in all phases of the disease (panel
C). Panel D shows Mfn-1 protein levels, Tg-CTRL mice
showed lower Mfn-1 level at 12 and 14 months of age with
respect to the age-matched WT-CTRL mice. As for PGC-1a,
exercise training significantly counteracted DRP1 and Mfn-1
reduction only in the late stage of the disease (14 months of
age). The protein level of mitochondrial complexes was also
evaluated and no significant changes were found among the
different experimental groups (panel E).
DISCUSSION
Tacking advantage of Tgaq*44 mouse model with pro-
tracted development of chronic heart failure (CHF), we
investigated the effect of voluntary exercise in normalizing
skeletal muscle oxidative stress during the progression of
CHF.
Voluntary exercise, despite not affecting key molecular
parameters related to skeletal muscle oxidative metabo-
lism, turned out an effective stimulus to counteract
oxidative stress in skeletal muscle of cardiopathic mice.
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This positive effect was observed before the onset of the
end-stage of CHF and appears to be mediated by the
induction of pathways involved in the protein quality
control and associated with improvement of physical
activity level and cardiac function.
Voluntary exercise positively affects
physical activity level and cardiac function
The in vivo muscle performance was analyzed by mea-
suring the covered distance and time of activity after
2 months of voluntary wheel running. Availability of
the running wheel in the cage determined a significantly
increased level of spontaneous activity, both in wild-
type and transgenic mice as indicated by the significant
increase in daily distance covered after exercise. This is
in agreement with the improved running capacity that
has been observed with voluntary wheel running exer-
cise in rats with CHF (Schultz et al., 2013). Voluntary
exercise was also able to eliminate the difference in
daily performance between wild-type and cardiopathic
mice present before exercise at 12 months of age.
Despite the beneficial effect of exercise, transgenic mice
showed a functional impairment in the late stage of
disease (14 months), as shown by the significant reduc-
tion in daily activity and weekly distance and time of
running.
In cardiopathic mice at the early stage of the disease
the cardiac performance is still preserved (Tyrankiewicz
et al., 2017). During the progression of CHF a progressive
impairment of ventricular and atrial functions occurred
as indicated by the increased number of cardiac parame-
ters compromised in the intermediate and final phases of
the disease compared to the early phase. Furthermore, the
peripheral consequences of progressing CHF may be
observed as more profound impairment in running activ-
ity at the finale stage of the disease, in agreement with
previous observations showing an evident cardiac decom-
pensation at ~14 months of age, leading to the phenotype
of end-stage heart failure (Elas et al., 2008; Mackiewicz
et al., 2012; Czarnowska et al., 2016; Tyrankiewicz et al.,
2017).
Exercise training improved ventricular and atrial func-
tions (cardiac index, end systolic volume, end diastolic
volume, stroke volume ejection fraction, left atrial ejection
fraction) both at the early and transition phase of CHF (6
and 12 months), but not in the advanced state of the dis-
ease (14 months of age), indicating that the improved
cardiac function, at least in part, contributes to the
improved physical activity level found at the early and
transition phase of CHF.
Voluntary exercise protected muscle from
CHF-induced oxidative stress in the
transition phase of the disease
Considering the oxidative stress can contribute to skeletal
muscle functional impairment (Kuwahara et al., 2010),
we investigated these aspects in our animal model during
the progression of the disease. In a normal and healthy
situation, a basal level of antioxidant enzymes is main-
tained to protect against deleterious effects of free
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radicals. The decreased SOD1 and catalase levels found
early and at the advanced stages of the disease, provide
the basis for ROS accumulation (Brocca et al., 2010).
Consistently, a significant increase in protein carbonyla-
tion was found both at 12 and 14 months. These results
confirm the accepted view that redox imbalance and
oxidative stress occur in skeletal muscle of CHF patients/
animals (Linke et al., 2005; Coirault et al., 2007; Bowen
et al., 2015). Considering that a deleterious effect on
in vitro myosin mechanical function due to myosin car-
bonylation has been reported in skeletal muscle of rats
with CHF (Coirault et al., 2007), and that in vivo perfor-
mance is negatively affected by excessive ROS production
(Kuwahara et al., 2010), it is reasonable to hypothesize
that in mice with CHF protein carbonylation could be
responsible, at least in part, for the development of skele-
tal muscle dysfunction and physical activity decline.
Regular physical activity can prevent oxidative stress by
either increasing the antioxidant defenses of skeletal mus-
cle (Brooks et al., 2008) or normalizing the oxidized pro-
teins level, through induction of systems responsible for
their elimination (Pasiakos et al., 2010). In Tgaq*44 mice,
exercise was able to ensure normal levels of protein oxi-
dation at 12 but not at 14 months of age, when the dam-
age was presumably too extensive to be overcome by
exercise. Carbonylation is an irreversible oxidative process
and carbonylated proteins are marked for proteolysis by
the proteasome that acts as reactive carbonyl scavenger
(see discussion below). Considering that at the beginning
of exercise 12-month-old transgenic mice are character-
ized by high level of carbonylated proteins, it is reason-
able to think that exercise improves systems responsible
for their elimination. Moreover, the absence of carbonyla-
tion obtained with exercise in cardiopathic mice in the
intermediate phase of the disease (12 months) also sug-
gests that endogenous defense systems, acting as ROS
scavenger, are efficient at keeping disease-induced ROS at
the control level. In this context, SOD and catalase do
not appear to be responsible for this effect. To effectively
neutralize ROS, an increase in expression of both SOD1
and catalase is required. Whereas SOD1 levels were
increased by training at 14 months, no effects of training
on catalase levels were observed in this study at any time-
point. This suggests that other antioxidant proteins take
part in this process. In fact, it is known that free radicals
are neutralized by an elaborate antioxidant defense sys-
tem, including glutathione and numerous nonenzymatic
antioxidants (Valko et al., 2007).
Interestingly, the antioxidant effect of exercise found in
cardiopathic mice at 12 months was associated with a sig-
nificant improvement of physical activity that was no dif-
ferent from that of trained wild type mice at the same
age. Instead, at the end stage of CHF (14 months), the
physical performance was significantly compromised and
associated with the accumulation of carbonylated pro-
teins. Thus, voluntary physical activity, has a beneficial
effect in countering skeletal muscle oxidative stress in
Tgaq*44 mice, but only before the attainment of the end-
stage of CHF.
The improved physical activity level induced
by training was associated with induction
of protein quality control systems
Maintenance of muscle performance relies on a baseline
turnover of mechanically unfolded and damaged proteins,
preventing cytotoxic accumulation of aggregates. Exercise
training-induced skeletal muscle adaptation likely requires
both addition and clearance of cellular components.
Therefore, it is believed that proteolysis processes play a
role in healthy skeletal muscle adaptation and post-exer-
cise remodeling (Bell et al., 2016). In this study, the ubiq-
uitin–proteasome markers were unaffected by CHF at the
early stage of the disease, whereas they decreased in the
crucial period of the transition from compensated hyper-
trophy to decompensated CHF (12 months). A similar
trend was observed for autophagic markers. Considering
that carbonylated proteins accumulated at 12 and
14 months and that the ubiquitin–proteasome system is
involved in their degradation (Davies, 2001), it can be
concluded that adaptations of protein quality control sys-
tems were not favorable for homeostasis maintenance.
Decrease in proteasome activity has been indicated in the
diaphragm of rats with CHF (Bowen et al., 2015). Reduc-
tion or lack of induction of proteasome and autophagy
may both cause and result from increased levels of oxi-
dized proteins. Persistently high ROS levels, in fact, may
lower the efficiency of the ubiquitin–proteasome system,
as a consequence of its susceptibility to oxidative stress
(Bulteau et al., 2001). Therefore, a higher level of oxida-
tive stress, as indicated by the high levels of protein car-
bonylation, likely impaired protein control systems in
Tgaq*44 mice at the age of 12 and 14 months. This con-
clusion seems to contradict the overactivation of protea-
somal activity in presence of protein carbonylation
observed in a mouse model of CHF induced by sympa-
thetic hyperactivity (Cunha et al., 2012a; Cunha et al.,
2012b). However, it might be hypothesized that between
6 and 12 months of age an overinduction of protein con-
trol systems actually occurred in Tgaq*44 mice, preceding
the subsequent impairment observed at 12 months.
Several evidences have shown that exercise induces a
general upregulation of ubiquitin–proteasome level both
in humans (Stefanetti et al., 2015) and mice (Cunha
et al., 2012b). Furthermore, autophagy activation in skele-
tal muscle following a single bout of forced treadmill
2019 | Vol. 7 | Iss. 13 | e14161
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exercise (Grumati et al., 2011; He et al., 2012), as well as
after prolonged voluntary wheel-running exercise (Lira
et al., 2013) has been reported. In agreement with this, in
this study exercise training resulted in an upregulation of
the ubiquitin proteasome and autophagy markers. Such
effect was observed only in the early and transition stages
of CHF, in which the in vivo improved functional perfor-
mance obtained by training was similar to that of the
age-matched WT trained mice and no protein carbonyla-
tion occurred.
Collectively, our results indicate that at stages preceding
the end-stage disease, but not at the end-stage of CHF,
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exercise training improved the expression of such systems,
preventing oxidized proteins accumulation and contribut-
ing to maintaining the in vivo performance. These results
also confirm that an over-activation of skeletal muscle
proteolytic systems is not restricted to atrophying states
and plays a role in maintaining cellular homeostasis.
Improvement of physical activity level
occurred without normalization of
molecular factors involved in oxidative
metabolism
To verify whether the positive effect of free wheel running
on physical activity level was mediated, at least in part, by
the correction of muscle metabolic defects associated with
CHF, we investigated this aspect during the progression
of the disease.
Acting as a major cellular energy sensor, AMPK has a
central role in reprogramming cellular metabolism from
anabolism to catabolism. This energy switch controls sev-
eral cellular processes, including mitochondrial homeosta-
sis (Herzig and Shaw, 2018). Tgaq*44 mice showed a
basal AMPK signaling suppression, in all phases of the
disease. Since PGC-1a has a prominent role in metabolic
adaptations to the energetic status, its activity might be
targeted by cellular mechanisms capable to sense
perturbations in cellular energy balance. One of these
mechanisms is represented by AMPK. Phosphorylation of
PGC-1a by AMPK is, therefore, part of the link between
the sensing of the energetic status and the induction of
transcriptional programs that control energy expenditure.
Decreased PCG-1a levels have been found in an animal
model of heart failure, both in cardiac (Knowlton et al.,
2014) and skeletal muscle (Ventura-Clapier et al., 2004).
Accordingly, we found decreased PCG-1a levels in
Tgaq*44 mice starting at the early stage of the disease,
also in agreement with the slow to fast MHC isoforms
transition. It is, in fact, known that PCG-1a drives the
formation of slow-twitch muscle fibers (Lin et al., 2002).
The data clearly show the AMPK- PGC-1a axis is
depressed early and during the progression of CHF in
Tgaq*44 mice. It is widely established that AMPK is acti-
vated in response to the increased energetic load pro-
duced by exercise and AMPK activation in skeletal muscle
during exercise improves athletic performance (Jørgensen
et al., 2005). Furthermore, it is known a profission
responses in mitochondrial dynamics mediated by AMPK
(Toyama et al., 2016) and exercise (Trewin et al., 2018)
later followed by a profusion adaptive responses. Mito-
chondrial dynamics is essential for mitochondrial viability
and response to changes in cellular bioenergetics status.
Change in metabolic demand regulates the rate of fission
and fusion causing mitochondria to become either
fragmented or hypertubular (Srivastava, 2017). In this
study, exercise increased AMPK level which in principle
could contribute to the improved physical activity level.
However, no increase in several direct or indirect targets
of AMPK related to mitochondrial biogenesis and dynam-
ics was observed until the age of 12 months, that is, at
times when physical activity level increased, whereas they
increased at 14 months, that is, at time when Tg mice
develop exercise intolerance. In this context, the restoring
of normal muscle phenotype observed in exercised cardio-
pathic mice did not occur as a function of PGC-1a con-
tent, in agreement with the concept that endurance
exercise-induced fiber-type transformation in skeletal
muscle can occur independently from the function of
PGC-1a (Geng et al., 2010). Accordingly, we can con-
clude that the keys factors involved in mitochondrial bio-
genesis and dynamics did not contribute to the
improvement of physical activity level induced by volun-
tary exercise even in fast muscle. It is tempting to specu-
late that mitochondrial remodeling in skeletal muscles is
triggered only when prolonged exercise was not able to
improve cardiac function as a last resort to improve phys-
ical activity level increasing the cellular oxidation capacity
(Herzig and Shaw, 2018).
In summary, the Tgaq*44 mouse model gave us the
opportunity to evaluate the effect of prolonged regular
exercise on cardiac function, skeletal muscle adaptations
and physical activity level during the progression of CHF
from the compensated to the uncompensated state of
the disease. The training modality used in this study, in
which work rate cannot be determined, does not allow
us to suggest specific exercise prescriptions to be extrap-
olated to other animal species or to humans. What we
can conclude is that the observed results were obtained
by a prolonged voluntary submaximal exercise training
intervention that in the early/transition stages of CHF,
despite not affecting molecular factors involved in skele-
tal muscle oxidative metabolism, leads to positive effects
not only on cardiac function but also in skeletal muscle
reducing oxidative damage and thus representing a use-
ful therapeutic modality to counteract physical activity
decline.
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